News

Filter

Current filters:

Pegaspargase

1 to 9 of 17 results

Enzon gets Orphan Drug status for new version of Oncaspar

06-10-2008

New Jersey, USA-based Enzon Pharmaceuticals has received European Orphan Drug designation for its Oncaspar-IV…

AsparaginaseElsparOncasparPegaspargase

Enzon swings to $286M loss in 4th-qtr 2005

13-03-2006

The USA's Enzon Pharmaceuticals says that, for the three months ended December 31, 2005, it saw a net…

AbelcetAdagenAmbisomeAmphotericin BAsparaginaseCytarabineCytarabine Liposome InjectionDepoCytElsparFungizoneOncasparPegademase BovinePegaspargase

JPMA issues guidelines for research tool patent

30-01-2006

The Japan Pharmaceutical Manufacturer's Association has announced guidelines for licensing research tool…

ArranonBuphenylDrug DiscoveryGlaxoSmithKlineGSKNelarabineNovartisOncasparOxcarbazepinePegaspargaseSodium Phenylbutyrate TabletsTrileptal

Enzon regains rights to cancer drug OncaSpar

15-07-2002

Aventis has returned all rights to Oncaspar (pegaspargase), used as atreatment for certain forms of cancer…

Aventis PharmaOncasparPegaspargase

Progress Revealed At Enzon

09-12-1996

Enzon executives speaking at the firm's annual meeting for shareholders said that the US biopharmaceutical…

AlbuminAlbuminarAntihemophilic FactorAsparaginaseBuminate 5%Coagulation Factor VIIaElsparOncasparPegaspargaseRecombinant

1 to 9 of 17 results

Back to top